ATPase Subunit G2 (ATP5MGL): A Promising Drug Target and Biomarker

Target Name: ATP5MGL

NCBI ID: G267020

ATP5MGL

ATPase Subunit G2 (ATP5MGL): A Promising Drug Target and Biomarker

ATP (adenylyl cyclic phosphate) is a crucial energy source for the cell and serves as the energy transporter for the majority of cellular processes. The ATPase subunit G2 (ATPase subunit G2, or ATP5MGL) is a protein that plays a critical role in the regulation of ATPase activity and is expressed in various cell types. The identification of ATP5MGL as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases.

The Importance of ATPase Subunit G2

ATPase subunit G2 is a key component of the ATPase enzyme complex, which is responsible for the active transport of ATP across the membrane. The ATPase enzyme is a transmembrane protein that uses ATP as its energy source to maintain the integrity of various cellular structures and to regulate various cellular processes. The ATPase subunit G2 plays a crucial role in regulating the ATPase active site, which is critical for the proper functioning of the ATPase enzyme.

ATPase Subunit G2 has been shown to be involved in various cellular processes, including cell signaling, DNA replication, and cell survival. It has been shown to play a role in the regulation of cell proliferation, differentiation, and apoptosis. Additionally, ATPase subunit G2 has been linked to the regulation of cellular responses to various stimuli, including those that affect the levels of intracellular calcium ions (Ca2+) and reactive oxygen species (ROS).

The Potential Role of ATPase Subunit G2 as a Drug Target

The identification of ATPase subunit G2 as a potential drug target has significant implications for the development of new therapeutic approaches for various diseases. The ability to target ATPase subunit G2 and modulate its activity could provide new avenues for the treatment of a wide range of conditions.

One of the key advantages of targeting ATPase subunit G2 is its potential to act as a biomarker for the treatment of certain diseases. The regulation of ATPase subunit G2 activity is closely linked to the regulation of cellular processes that are affected by various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. By modulating ATPase subunit G2 activity, researchers may be able to develop new diagnostic tools and therapeutic approaches for these diseases.

In addition to its potential as a drug target, ATPase subunit G2 has also been shown to be involved in the regulation of cellular processes that are critical for human health. The regulation of ATPase subunit G2 activity by various chemical and biological factors has been shown to play a role in the development and progression of a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The Potential of ATPase Subunit G2 as a therapeutic agent is further enhanced by its location on the membrane of various cell types. As a protein that is expressed in various cell types, ATPase subunit G2 is accessible to a wide range of therapeutic agents, including small molecules, antibodies, and other protein-based agents. This accessibility makes ATPase subunit G2 an attractive target for the development of new therapeutic approaches for a wide range of diseases.

Conclusion

In conclusion, the identification of ATPase subunit G2 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases. The regulation of ATPase subunit G2 activity by various chemical and biological factors plays a critical role in the development and progression of a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The identification of ATPase subunit G2 as a potential drug target has the potential to

Protein Name: ATP Synthase Membrane Subunit G Like

Functions: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. Minor subunit located with subunit a in the membrane (By similarity)

The "ATP5MGL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP5MGL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets